Medicine and Dentistry
Acute Pancreatitis
98%
Distal Pancreatectomy
81%
Pancreaticoduodenectomy
77%
Surgery
67%
Recurrent Disease
64%
Pancreas Cancer
60%
Retrospective Cohort Study
58%
Pancreas Adenocarcinoma
47%
Overall Survival
39%
Triacylglycerol
38%
Clear Cell Renal Cell Carcinoma
38%
Metastatic Carcinoma
38%
Surgery
38%
Pancreas Necrosis
30%
Prognostic Factor
23%
APACHE II
23%
Hospital Mortality
23%
Endoscopic Ultrasound
22%
C Reactive Protein
21%
Retrospective Study
20%
Diagnosis
19%
Meta-Analysis
19%
Systematic Review
19%
Pancreas Cyst
19%
Liquid Biopsy
19%
Elastography
19%
Infection
19%
Circulating Tumor DNA
19%
Adjuvant Chemotherapy
19%
Cholangitis
19%
Procalcitonin
19%
Splenectomy
19%
Blood Urea Nitrogen
19%
Dysplasia
19%
Observational Study
19%
Prospective Cohort Study
19%
Adenocarcinoma
19%
Comorbidity
19%
Diseases
19%
Pancreatic Surgery
15%
Disease Free Survival
14%
Pancreas Fistula
13%
Operation Duration
12%
Intensive Care Unit
12%
Bleeding
10%
Logistic Regression Analysis
10%
Laparoscopic Surgery
9%
Endoscopic Retrograde Cholangiopancreatography
9%
Antibiotics
9%
Body Mass Index
9%
Keyphrases
Acute Pancreatitis
100%
Pancreaticoduodenectomy
77%
Resectable Pancreatic Cancer
60%
Serum Triglycerides
38%
Overall Survival
34%
Pancreatic Necrosis
29%
Severe Acute Pancreatitis
27%
Whipple
27%
Resection
25%
Prognostic Factors
25%
Pancreas
25%
Minimally Invasive Distal Pancreatectomy
24%
Triglycerides
24%
Multivariable
24%
Carbohydrate Antigen 19-9 (CA19-9)
22%
5-year Survival
22%
Triglyceride Level
22%
Multicenter Retrospective Cohort Study
20%
High Triglycerides
19%
Associated Complications
19%
Systematic Meta-analysis
19%
Severe Morbidity
19%
Adjuvant Chemotherapy
19%
Periarterial Divestment
19%
Severity Prediction
19%
Borderline Resectable
19%
Liquid Biopsy
19%
Laparoscopically Assisted
19%
Laparoscopic Spleen-preserving Distal Pancreatectomy
19%
Clinically Significant
19%
Pancreatic Metastasis
19%
Intra-abdominal Collection
19%
Ampullary Adenocarcinoma
19%
Low Dose Rate
19%
Oncological Outcomes
19%
Circulating Tumor DNA (ctDNA)
19%
Pancreatic Adenocarcinoma
19%
Splenectomy
19%
Bedside Index for Severity in Acute Pancreatitis
19%
European multicentre Study
19%
Meta-analysis
19%
Serious Complications
19%
Artificial Intelligence Applications
19%
International multicenter Study
19%
Laparoscopic Distal Pancreatectomy
19%
Acute Cholangitis
19%
Comorbidity
19%
Renal Cell Carcinoma
19%
Elastography
19%
Severity Index
19%